Ra mắt thuốc kháng thể chống COVID-19 có hiệu quả bảo vệ trong 6 tháng

(TTXVN/Vietnam+) 19:14 18/11/2021

Ngày 18/11, hãng dược phẩm AstraZeneca (Anh-Thụy Điển) cho biết thuốc kháng thể chống COVID-19 dạng tiêm mang tên Evusheld của hãng này cho hiệu quả bảo vệ lên đến 83% trong vòng 6 tháng.

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